Ra mắt thuốc kháng thể chống COVID-19 có hiệu quả bảo vệ trong 6 tháng

(TTXVN/Vietnam+) 19:14 18/11/2021

Ngày 18/11, hãng dược phẩm AstraZeneca (Anh-Thụy Điển) cho biết thuốc kháng thể chống COVID-19 dạng tiêm mang tên Evusheld của hãng này cho hiệu quả bảo vệ lên đến 83% trong vòng 6 tháng.

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